Ra mắt thuốc kháng thể chống COVID-19 có hiệu quả bảo vệ trong 6 tháng

(TTXVN/Vietnam+) 19:14 18/11/2021

Ngày 18/11, hãng dược phẩm AstraZeneca (Anh-Thụy Điển) cho biết thuốc kháng thể chống COVID-19 dạng tiêm mang tên Evusheld của hãng này cho hiệu quả bảo vệ lên đến 83% trong vòng 6 tháng.

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